Ra mắt thuốc kháng thể chống COVID-19 có hiệu quả bảo vệ trong 6 tháng

(TTXVN/Vietnam+) 19:14 18/11/2021

Ngày 18/11, hãng dược phẩm AstraZeneca (Anh-Thụy Điển) cho biết thuốc kháng thể chống COVID-19 dạng tiêm mang tên Evusheld của hãng này cho hiệu quả bảo vệ lên đến 83% trong vòng 6 tháng.

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